Headache Treatments
Michael A. Rogawski, M.D., Ph.D.
  • Home
  • Search
  • Testing Routine Blood Migraine
  • Acute Migraine Treatment (status migrainosus), Triptans, NSAIDs
  • CGRP Antibodies and Gepants
  • Preventative Migraine Treatments
  • NSAID
  • Headache Types
  • Emergency Department Treatment
  • Tension Type Headache
  • Indomethacin Responsive Headaches
  • Children and Adolescents
  • Medication Overuse Headache
  • IV Infusion Protocols
  • Posttraumatic Headache
  • Migraine Mimics
  • High and Low Pressure Headache
  • Devices
  • Lawrence Robbins: Advanced Headache Therapy
  • Hemiplegic Migraine
  • Cluster Headache Treatment
  • Headache Tracking
  • Sleep - Insomnia
  • Triggers/Caffeine
  • Depression Screening PHQ-2 and PHQ-9
  • Publications
  • Menstruation, Pregnancy and Breastfeeding
  • Contraception - Birth Control
  • Menopause - Menopausal Vasomotor Symptoms
  • Butterbur
  • Prodrome and Aura
  • Tinnitus
  • Neck Pain; Spinal Anatomy & Dermtomes
  • Behavioral Therapy
  • Exercise
  • Magnesium, Nutritional Supplements and Alternative
  • Hypertension Guidlines
  • MIDAS (Migraine Disability Assessment) and ASC-12
  • Botox
  • Vestibular Migraine
  • Nerve Blocks
  • Cannabinoids
  • Deprescribing/ Withdrawing Medications
  • Epilepsy/Seizure Drugs in Development
  • Occipital Epilepsy
  • Chronic Pain / Back Pain
  • HIT-6 Headache Impact Test
  • Thunderclap Headache
  • Cerebral Vascular Anatomy
  • Nonpharmacological Measures
  • SphenoCath

Drug Withdrawal

Picture
Bain KT, Holmes HM, Beers MH, Maio V, Handler SM, Pauker SG. Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process. J Am Geriatr Soc. 2008 Oct;56(10):1946-52.

Deprescribing SSRIs

Picture
More than half (56%) of antidepressant users experience withdrawal, with the majority of these describing their withdrawal as moderate or severe, and nearly half (46%) as severe.
Davies J, Read J. A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based? Addict Behav. 2018 Sep 4. pii: S0306-4603(18)30834-7.

Deprescribing Benzodiazepines

Pottie et al. Deprescribing benzodiazepine receptor agonists. Evidence-based clinical practice guideline Canadian Family Physician May, 2018.pottie_deprescribing_benzodiazepine_receptor_agonists._evidence-based_clinical_practice_guideline_canadfamphysician2018l.pdf
Download Deprescribing Benzodiazepines PDF
Picture
Picture